Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Generic Biologics Commission Urged; McCain Abjures Bioterrorism Add-On

Executive Summary

Sen. Jay Rockefeller (D-W.Va.) is expected to introduce legislation that would create a commission to examine the possibility of generic biologics

You may also be interested in...



Rockefeller Generic Rx Bill Would Penalize Brands For Failed Patent Defense

Generic drug legislation floated by Sen. Jay Rockefeller (D-W.Va.) would create a drug reimbursement fund to compensate parties denied access to generic drugs due to litigation

Rockefeller Generic Rx Bill Would Penalize Brands For Failed Patent Defense

Generic drug legislation floated by Sen. Jay Rockefeller (D-W.Va.) would create a drug reimbursement fund to compensate parties denied access to generic drugs due to litigation

Rockefeller generic bill

Sen. Jay Rockefeller (D-W.Va.) is expected to introduce legislation addressing use of generic drugs and biologics during the week of June 17 (1"The Pink Sheet" May 6, p. 9)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039777

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel